Skandinaviska Enskilda Banken (SEB)
KYMR icon

Skandinaviska Enskilda Banken (SEB)’s Kymera Therapeutics KYMR Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,141
Closed -$1.66M – 848
2025
Q2 		$1.66M Hold
38,141
– – 0.01% 598
2025
Q1 		$1.04M Hold
38,141
– – 0.01% 633
2024
Q4 		$1.5M Hold
38,141
– – 0.01% 615
2024
Q3 		$1.81M Hold
38,141
– – 0.01% 604
2024
Q2 		$1.14M Hold
38,141
– – 0.01% 629
2024
Q1 		$1.53M Buy
+38,141
New +$1.36M 0.01% 618

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return